
("Ferro-Alloy" or "the Company")
Notice of AGM
The Notice of AGM, which sets out the arrangements for the meeting and how shareholders may vote, has been sent in hard copy to the registered shareholders of the Company and is available on the Company's website: www.ferro-alloy.com.
ENDS
For further information, visit www.ferro-alloy.com or contact:
|
|
|
(Joint Corporate Broker)
(Joint Corporate Broker)
BlytheRay (Financial PR) |
|
+44 207 408 4090
+44 20 3100 2000
+44 20 7138 3204 |
Notes to Editors
About
The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskoye Oblast in the South of
Balasausqandiq is a very large deposit, with vanadium as the principal product together with the carbon black substitute ("
The most recent mineral resource estimate for ore-body one (of seven) provided an Indicated Mineral Resource of 32.9 million tonnes at a mean grade of 0.62% vanadium pentoxide ("V2O5") equating to 203,364 contained tonnes of V2O5. In the system of reserve estimation used in
The grade of carbon in the deposit is over 8%. The carbon flows through to the tailings from where it is concentrated, in a simple low-cost operation, into a 40% carbon product, the
The Project will be developed in two phases, Phase 1 and Phase 2, with Phase 1 treating 1.65 million tonnes per year.
There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant, which was then expanded and adapted to recover vanadium, molybdenum and nickel from purchased concentrates. Alongside this operation, there is a well-equipped laboratory and highly skilled technical team, who have already developed the technology that is being built into the feasibility study and is further developing and optimising processes needed for future vanadium and carbon operations. The plant will operate only when profitable concentrates are available and, when not operating as a production facility, will operate on an expanded basis as an R&D centre.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the